Imatinib mesylate is a targeted therapy drug used to treat Chronic myeloid leukemia, Acute lymphoblastic leukemia, Gastrointestinal stromal tumours, Hypereosinophilic syndrome, Dermatofibrosarcoma protuberans, Systemic mastocytosis, Myelodysplastic or myeloproliferative diseases.
Category:
I
-
-
-
“Ibritumomab tiuxetan is a targeted therapy drug used to treat Non-Hodgkin’s lymphoma and Follicular B-cell non-Hodgkin’s lymphoma.”
